IBEX Technologies Inc.
OTC: IBXNF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Paul Baehr
- Headquarters
- Montreal, Canada
- IPO year
- 2018
- Market cap
- $25.3M
- Website
- https://www.ibex.ca
Loading IBXNF…
Loading profile data…Frequently asked questions about IBXNF
What does IBEX Technologies Inc. (IBXNF) do?
Operating internationally, with key markets spanning Canada, the United States, Germany, and the United Kingdom, IBEX Technologies Inc. focuses on the development and sale of enzymes for various biomedical purposes. Its extensive product catalog includes a range of recombinant glycosaminoglycan lyases, such as Heparinase I, II, and III, alongsid...
Where does IBXNF trade?
IBEX Technologies Inc. (IBXNF) trades on the Other OTC.
What sector is IBXNF in?
IBEX Technologies Inc. (IBXNF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of IBEX Technologies Inc.?
Paul Baehr is the chief executive officer of IBEX Technologies Inc. (IBXNF).
Where is IBEX Technologies Inc. headquartered?
IBEX Technologies Inc. is headquartered in Canada.
Does IBXNF pay a dividend?
IBEX Technologies Inc. (IBXNF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IBXNF go public?
IBEX Technologies Inc. (IBXNF) completed its initial public offering in 2018.